Stocks
Health Care
cytk
Cytokinetics
NASDAQ: CYTK
-0.83 (-1.25%)
65.71
USD
At close at Dec 05, 21:38 UTC
Income Statement
Revenue
18.47M
Gross Profit
18.47M
Operating Income
-536.25M
Pretax Income
-751.92M
Net Income
-589.53M
EBITDA
-542.29M
EBIT
-551.83M
Earnings Per Share
-5.26
Balance Sheet
Cash & Cash Equivalents
112.97M
Total Debt
780.85M
Net Cash
-
Net Cash Per Share
-
Equity (Book Value)
-109.22M
Book Value Per Share
-0.99
Working Capital
-
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.